Welcome to LookChem.com Sign In|Join Free
  • or
4-chloro-benzaldehyde (5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)hydrazone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

301655-17-4

Post Buying Request

301655-17-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

301655-17-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 301655-17-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,1,6,5 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 301655-17:
(8*3)+(7*0)+(6*1)+(5*6)+(4*5)+(3*5)+(2*1)+(1*7)=104
104 % 10 = 4
So 301655-17-4 is a valid CAS Registry Number.

301655-17-4Downstream Products

301655-17-4Relevant academic research and scientific papers

COMPOUNDS, THEIR SYNTHESES, AND THEIR USES

-

Page/Page column 52, (2010/04/03)

Embodiments of the present invention provide compounds (such as Formula (I) compounds, Formula (II) compounds, and various embodiments thereof). Compositions comprising those compounds are also provided. Methods for their preparation are included. Also, uses of the compounds are included, such as administering and treating diseases (e.g., cancer and infections).

Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines

Aponte, José C.,Vaisberg, Abraham J.,Castillo, Denis,Gonzalez, German,Estevez, Yannick,Arevalo, Jorge,Quiliano, Miguel,Zimic, Mirko,Verástegui, Manuela,Málaga, Edith,Gilman, Robert H.,Bustamante, Juan M.,Tarleton, Rick L.,Wang, Yuehong,Franzblau, Scott G.,Pauli, Guido F.,Sauvain, Michel,Hammond, Gerald B.

supporting information; experimental part, p. 2880 - 2886 (2010/07/02)

The synthesis of 2-(5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-yl)hydrazone-derivatives (BTPs) and their in vitro evaluation against Trypanosoma cruzi trypomastigotes, Mycobacterium tuberculosis, Leishmania amazonensis axenic amastigotes, and six human cancer cell lines is described. The in vivo activity of the most active and least toxic compounds against T. cruzi and L. amazonensis was also studied. BTPs constitute a new family of drug leads with potential activity against infectious diseases. Due to their drug-like properties, this series of compounds can potentially serve as templates for future drug-optimization and drug-development efforts for use as therapeutic agents in developing countries.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 301655-17-4